Innoviva share price logo

Innoviva

NASDAQ: INVA

Small Cap

$20.65

+0.15

(+0.73%)

as on

Innoviva Stock Performance

as on October 6, 2026 at 6:59 am IST

  • Day's Low

    Day's High

    $20.46
    $20.71
    downward going graph

    0.92%

    Downside

    0.29%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $16.52
    $25.15
    downward going graph

    20.00%

    Downside

    21.77%

    Upside

    downward going graph

Innoviva share price movements today

Previous Close
$20.50
Open
$20.51
Volume
681.5K
Market Cap
$1.5B
Day's Low - High
$20.46 - $20.71
52 Week Low - High
$16.52 - $25.15

Innoviva Historical Returns

1 Month Return
-3.89 %
3 Month Return
-8.11 %
1 Year Return
+ 17.28 %
3 Year Return
+ 54.95 %
5 Year Return
+ 23.87 %

Innoviva Stock Fundamentals & Key Indicators

Check Innoviva market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$1.5B

EPS (TTM)

4.87

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

5.90%

PE Ratio (TTM)

4.21

Industry PE ratio

-6.25

PEG Ratio

0.01

EBITDA

823.3M

Revenue (TTM)

443.4M

Profit Margin

73.09%

Return On Equity TTM

30.03%

Innoviva vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Innoviva with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
StrongBuy$1.5B23.87%4.2173.09%0.00%
StrongBuy$44.3B637.21%-23.320.00%0.00%
Neutral$75.9B-42.79%-23.81-12.57%0.00%
StrongBuy$127.9B185.14%29.1486.04%0.00%
Buy$75.7B33.45%17.5584.86%0.50%

Stock Returns calculator for Innoviva Stock including INR - Dollar returns

The Innoviva stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Innoviva investment value today

Current value as on today

₹1,28,217

Returns

₹28,217

(+28.22%)

Returns from Innoviva Stock

₹18,135 (+18.14%)

Dollar Impact

₹10,082 (+10.08%)

Analyst Recommendation on Innoviva Stock

Based on 4 analysts

BUY

100.00%

Buy

0.00%

Hold

0.00%

Sell

Based on 4 analysts, 100% of analysts recommend a 'BUY' rating for Innoviva. Average target price of $35

Innoviva Share Price Target

Get share price movements and forecasts by analysts on Innoviva.

What analysts predicted

41%UPSIDE

Target Price

$35

Current Price

$20.65

Analyzed by

4 Analysts

High

$46

Target

$35.00

Low

$34

Innoviva target price $35, a slight upside of 41% compared to current price of $20.65. According to 4 analysts rating.

Indian Investors' Interest in Innoviva Stock

Search interest for Innoviva Stock has increased by 46% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:46% versus previous 30 day period

Innoviva Quarterly Profit & Loss

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Total Revenue
77
103
89
91
88
100
107
118
97
119
Gross Profit
66
84
79
84
79
89
82
75
75
90
Operating Income
25
54
49
43
-41
-48
34
38
38
50
EBITDA
57
-23
19
35
-27
83
108
208
239
267
Interest Expense
5
5
5
4
4
4
4
3
5
5
Depreciation
6
9
6
6
6
6
6
10
10
62
Income Before Tax
45
-39
6
24
-38
72
97
195
234
-108
Income Tax Expense
8
-4
5
4
7
8
7
30
47
-24
Net Income
36
-34
1
20
-46
63
89
164
186
-83
Net Profit Margin
85.84%
82.21%
88.84%
92.20%
90.02%
89.44%
76.09%
64.05%
77.39%
75.77%

Innoviva Annual Profit & Loss

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
217
261
261
336
391
331
310
358
425
Gross Profit
215
261
261
336
391
317
267
322
307
Operating Income
183
238
246
321
375
206
113
166
163
EBITDA
205
248
260
372
478
308
235
85
383
Interest Expense
43
23
18
18
19
15
19
22
16
Depreciation
13
13
13
-
13
5
21
25
40
Income Before Tax
134
210
232
354
445
286
194
37
326
Income Tax Expense
0
-196
41
60
76
66
14
13
55
Net Income
134
395
157
224
265
213
179
23
271
Net Profit Margin
99.38%
100.00%
100.00%
100.00%
100.00%
95.84%
86.27%
89.80%
72.33%

Innoviva Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Net Income
36
-34
1
20
-46
63
89
241
186
-83
Operating Cash Flow
37
43
48
59
48
44
49
54
35
51
Investing Cash Flow
-43
-
-5
-15
-34
33
18
23
37
-55
Financing Cash Flow
-9
-5
0
0
0
1
10
-3
-20
-29
Change in Cash
-15
38
43
44
14
78
78
74
52
-32

Innoviva Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
134
406
190
293
368
220
179
23
271
Operating Cash Flow
141
223
257
313
363
201
141
188
196
Investing Cash Flow
-23
3
-18
-314
43
-56
-66
-63
40
Financing Cash Flow
-163
-237
-23
-29
-452
-55
-171
-13
8
Change in Cash
-44
-10
215
-31
-44
89
-97
111
245

Global Institutional Holdings in Innoviva

Check out the Institutions with significant holdings in Innoviva.

Funds
Holdings
iShares
11.62%
Vanguard
9.58%
VANGUARD INDEX FUNDS
7.86%
DFA INVESTMENT DIMENSIONS GROUP INC
3.38%
SPDR
2.24%

Insights on Innoviva

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 2 quarters, 97.99M → 119.59M (in $), with an average increase of 18.1% per quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Moderna, Inc. Common Stock has given 566.9% return, outperforming this stock by 549.6%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Revolution Medicines, Inc. Common Stock has given 84.5% return, outperforming this stock by 29.5%

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Netprofit is down for the last 2 quarters, 186.59M → -83.42M (in $), with an average decrease of 144.7% per quarter

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 7 days, INVA stock has moved down by -3.4%

About Innoviva

Innoviva, Inc. functions as a pharmaceutical company, concentrating on the worldwide creation and marketing of medical treatments. Its current product lineup prominently includes several once-daily combination therapies: RELVAR/BREO ELLIPTA, which integrates vilanterol (a long-acting beta2 agonist, or LABA) with fluticasone furoate (an inhaled corticosteroid, or ICS); ANORO ELLIPTA, a medication that pairs umeclidinium bromide (a long-acting muscarinic antagonist, or LAMA) with vilanterol (LABA); and TRELEGY ELLIPTA, a comprehensive treatment combining an ICS, LAMA, and LABA. The company has forged a key strategic alliance with Sarissa Capital Management LP. Moreover, Innoviva collaborates with Glaxo Group Limited under an agreement focused on the development and commercialization of daily LABA-based products designed to treat chronic obstructive pulmonary disease and asthma. Founded in 1996, the corporation was initially known as Theravance, Inc., before officially changing its name to Innoviva, Inc. in January 2016. Its primary operational base is situated in Burlingame, California.
OrganisationInnoviva
Headquarters1350 Old Bayshore Highway, Burlingame, CA, 94010, US
IndustryBiotechnology
CEOPavel Raifeld

Key Management of Innoviva

Name

Title

Dr. David Altarac M.D., MPA

Chief Medical Officer of IST

Mr. Pavel Raifeld C.F.A.

CEO & Director

Mr. Stephen Basso M.B.A.

Chief Financial Officer

Ms. Marianne Zhen CPA

Chief Accounting Officer & Secretary

Ms. Patricia M. Drake

Chief Commercial Officer-Innoviva Specialty Therapeutics, Inc.

FAQs

What is Innoviva share price today?

Innoviva share price today is $20.65 as on at the close of the market. Innoviva share today touched a day high of $20.71 and a low of $20.46.

What is the 52 week high and 52 week low for Innoviva share?

Innoviva share touched a 52 week high of $25.15 on and a 52 week low of $16.52 on . Innoviva stock price today i.e. is closed at $20.65,which is 17.88% down from its 52 week high and 25.00% up from its 52 week low.

What is Innoviva's market capitalisation today?

Innoviva market capitalisation is $0.00T as on .

How to invest in Innoviva Stock (INVA) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Innoviva on INDmoney app. Click on Buy button.

What is the minimum amount required to buy Innoviva Stock (INVA) from India?

Indian investors can start investing in Innoviva (INVA) shares with as little as ₹96.292503356934 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹962.93 in Innoviva stock (as per the Rupee-Dollar exchange rate as on ). Based on Innoviva share’s latest price of $20.65 as on October 6, 2026 at 1:29 am IST, you will get 0.4843 shares of Innoviva. Learn more about fractional shares .

What are the returns that Innoviva has given to Indian investors in the last 5 years?

Innoviva stock has given 23.87% share price returns and 29.18% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?